Michael May, CEO of Centre for Commercialization of Regenerative Medicine (Canada)
RMF’s Bernie Siegel talks with Michael May of CCRM about the future of stem cell development
- ‘Blastoids’ made of stem cells offer a new way to study fertility
- Reimagining stem cell cultivation
- Stem Cells or PRP for Equine Tendon and Ligament Injuries?
- First-ever pig-to-human heart transplant offers hope for thousands in need of organs
- Bayer Strikes “Mammoth” CRISPR Deal to Bolster Cell and Gene Therapy